Therapy-related myelodysplastic syndrome with trisomy 1q due to der(1;7) and megakaryoblastic proliferation developing during complete remission of therapy-related acute myeloid leukemia with t(8;21)

被引:7
作者
Sakai, C
Matsubayashi, K
Saotome, T
Ishii, A
Kumagai, K
机构
[1] Chiba Canc Ctr Hosp, Div Hematol Oncol, Chuo Ku, Chiba 2608717, Japan
[2] Chiba Canc Ctr Hosp, Dept Clin Lab, Chiba 2608717, Japan
关键词
T-cell lymphoma; topoisomerase II inhibitors; alkylating agents; CD41;
D O I
10.2169/internalmedicine.43.582
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Therapy-related acute myeloid leukemia (t-AML) with t(8;21) and therapy-related myelodysplastic syndrome (t-MDS) with trisomy 1q due to der(1;7) developed in the same patient with T-cell lymphoma at intervals of six years. After the development of t-MDS with trisomy 1q, during complete remission of t-AML, the number of megakaryoblasts increased to maximally 74% of leukocytes in the blood. This is a very rare case of two separate therapy-related myeloid malignancies (early t-AML and late t-MDS) and. is also a notable case of t-MDS with trisomy 1q due to der(1;7) accompanied by megakaryoblastic proliferation.
引用
收藏
页码:582 / 586
页数:5
相关论文
共 23 条
  • [1] Increased frequency of dicentric chromosomes in therapy-related MDS and AML compared to de novo disease is significantly related to previous treatment with alkylating agents and suggests a specific susceptibility to chromosome breakage at the centromere
    Andersen, MK
    Pedersen-Bjergaard, J
    [J]. LEUKEMIA, 2000, 14 (01) : 105 - 111
  • [2] BRUNNING RD, 2001, PATHOLOGY GENETICS T, P99
  • [3] CARROLL A, 1991, BLOOD, V78, P748
  • [4] Cytogenetic profile of childhood and adult megakaryoblastic leukemia (M7):: a study of the Groupe Francais de Cytogenetique Hematologique (GFCH)
    Dastugue, N
    Lafage-Pochitaloff, M
    Pagès, MP
    Radford, I
    Bastard, C
    Talmant, P
    Mozziconacci, MJ
    Léonard, C
    Bilhou-Nabéra, C
    Cabrol, C
    Capodano, AM
    Cornillet-Lefebvre, P
    Lessard, M
    Mugneret, F
    Pérot, C
    Taviaux, S
    Fenneteaux, O
    Duchayne, E
    Berger, R
    [J]. BLOOD, 2002, 100 (02) : 618 - 626
  • [5] PARTIAL TRISOMY-1Q - A NONRANDOM PRIMARY CHROMOSOMAL ABNORMALITY IN MYELODYSPLASTIC SYNDROMES
    FONATSCH, C
    HAASE, D
    FREUND, M
    BARTELS, H
    TESCH, H
    [J]. CANCER GENETICS AND CYTOGENETICS, 1991, 56 (02) : 243 - 253
  • [6] AN IDENTICAL TRANSLOCATION BETWEEN CHROMOSOME-1 AND CHROMOSOME-7 IN 3 PATIENTS WITH MYELOFIBROSIS AND MYELOID METAPLASIA
    GERAEDTS, JPM
    OTTOLANDER, GJD
    PLOEM, JE
    MUNTINGHE, OG
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1980, 44 (04) : 569 - 575
  • [7] UNBALANCED 17 TRANSLOCATION IN MYELODYSPLASTIC SYNDROME FOLLOWING TREATMENT OF ACUTE MYELOBLASTIC-LEUKEMIA WITH AN 8,22 TRANSLOCATION
    HAMAMOTO, K
    HASHIMOTONINOMIYA, A
    KISHIMOTO, Y
    KIMURA, T
    FUJITAKE, H
    YASUNAGA, K
    HORIIKE, S
    [J]. CANCER GENETICS AND CYTOGENETICS, 1994, 74 (01) : 35 - 39
  • [8] HORIIKE S, 1990, CANCER, V65, P1350, DOI 10.1002/1097-0142(19900315)65:6<1350::AID-CNCR2820650617>3.0.CO
  • [9] 2-J
  • [10] KANTARJIAN HM, 1986, CANCER, V58, P924, DOI 10.1002/1097-0142(19860815)58:4<924::AID-CNCR2820580420>3.0.CO